Anaphylaxis is a severe, systemic hypersensitivity reaction that develops rapidly and can be fatal within minutes if untreated. It involves massive mast cell and basophil degranulation — releasing histamine, tryptase, prostaglandins, and leukotrienes — causing simultaneous cardiovascular collapse, airway compromise, and cutaneous symptoms. In the United States, approximately 1,500–2,000 deaths per year are attributed to anaphylaxis, with food, medications, and insect venom accounting for the majority of triggers.
The nursing priority is unambiguous: epinephrine first, everything else second. No other intervention takes precedence over IM epinephrine in confirmed or suspected anaphylaxis.
Quick reference
| Domain | Key facts |
|---|---|
| First-line treatment | Epinephrine 0.3 mg IM (adult) into the anterolateral thigh — not deltoid, not IV (unless arrest/refractory) |
| Repeat dosing | May repeat epinephrine every 5–15 minutes if no improvement; no maximum dose ceiling in anaphylaxis |
| Biphasic reaction | Recurrence of symptoms 4–12 hours after apparent resolution without re-exposure — observe minimum 4 hours, 8–24 hours if severe |
| Classic NCLEX trap | Diphenhydramine (Benadryl) is NOT first-line — antihistamines do not prevent airway closure or cardiovascular collapse |
| Positioning | Supine with legs elevated (shock); upright if respiratory distress; left lateral decubitus if pregnant |
| Anaphylactoid vs IgE-mediated | Anaphylactoid: direct mast cell degranulation, no prior sensitization required (contrast dye, ASA, opioids) |
| EpiPen dosing | Adult: 0.3 mg; pediatric (<30 kg): 0.15 mg — inject outer thigh through clothing, hold 10 seconds |
| Corticosteroids | Methylprednisolone or dexamethasone — reduce biphasic risk; onset 4–6 hours, NOT for acute resuscitation |
| Most common triggers | Foods (peanuts, shellfish, tree nuts), medications (penicillin, NSAIDs, chemotherapy), latex, insect venom |
| Airway priority | Prepare for intubation if laryngeal edema, stridor, or voice change — window closes rapidly |
Pathophysiology
Anaphylaxis begins with prior sensitization: on first antigen exposure, B-cells produce IgE antibodies specific to the antigen. These IgE molecules bind to high-affinity receptors (FcεRI) on the surface of mast cells and basophils throughout the body — particularly in the skin, airways, and gut. The patient is now sensitized but has no symptoms.
On re-exposure, the antigen cross-links two adjacent IgE molecules on the mast cell surface. This cross-linking triggers an intracellular signaling cascade that causes rapid degranulation — the mast cell explosively releases preformed mediators (histamine, tryptase, heparin) and synthesizes new ones (prostaglandins, leukotrienes, platelet-activating factor). The result is simultaneous effects across multiple organ systems:
- Vasodilation and increased permeability: Histamine and prostaglandins dilate arterioles and increase capillary permeability. Up to 35% of the circulating blood volume can shift out of the vascular space within minutes, causing distributive shock indistinguishable in presentation from septic shock.
- Bronchospasm: Leukotrienes (LTC4, LTD4) cause sustained smooth muscle contraction in the bronchi, producing the wheezing and air trapping pattern seen in severe asthma. Leukotriene-driven bronchospasm is more refractory to beta-agonists than histamine-driven spasm.
- Laryngeal edema: Edema of the supraglottic structures causes stridor, voice change, and rapidly progressive airway obstruction. This is the most immediately life-threatening feature — once the airway closes, even emergent cricothyrotomy may be too late.
- Cardiac effects: Histamine acts directly on H1 and H2 receptors in the myocardium, causing tachycardia, increased contractility initially, and then — as distributive shock deepens — hypotension and potential ischemia or arrest.
The entire cascade from antigen exposure to cardiovascular collapse can unfold in under five minutes with parenteral (IV or IM) antigen exposure. Oral antigen exposure generally produces a slower onset, but rate varies considerably.
Triggers by category and reaction timing
| Category | Common triggers | Typical onset after exposure | Notes |
|---|---|---|---|
| Foods | Peanuts, tree nuts, shellfish, fish, milk, eggs, wheat, soy | 5–30 minutes (faster with raw vs cooked) | Peanut and tree nut allergy rarely outgrown; shellfish reactions often most severe |
| Medications (IgE-mediated) | Penicillin and cephalosporins, insulin, latex-containing medical devices, vaccines (rare) | 1–30 minutes IV; up to 60 min oral | Cross-reactivity between penicillin and cephalosporins: ~1–2% (lower than historically taught) |
| Medications (anaphylactoid) | IV contrast dye, aspirin/NSAIDs, opioids (morphine, codeine), vancomycin ("red man syndrome") | Minutes to 30 minutes | No prior exposure required; vancomycin red man is rate-dependent — slow infusion prevents it |
| Insect venom | Hymenoptera: honeybee, yellow jacket, wasp, hornet, fire ant | 5–15 minutes | Bees leave stinger (scrape, don't squeeze); venom-specific immunotherapy highly effective for prevention |
| Latex | Latex gloves, catheters, IV tubing, elastic bandages | 5–60 minutes (contact) or minutes (mucosal) | Cross-reactive foods: banana, avocado, kiwi, chestnut ("latex-fruit syndrome") |
| Exercise-induced | Exercise alone (rare) or food-dependent (requires both food ingestion AND exercise) | During or shortly after exertion | Food-dependent exercise-induced: often wheat or shellfish; avoid trigger food 4–6h before exercise |
| Idiopathic | No identifiable trigger (up to 30–40% of adult cases) | Variable | Mast cell disorders (systemic mastocytosis) are an important cause of recurrent idiopathic anaphylaxis |
NCLEX tip 1: Anaphylactoid reactions produce clinically identical symptoms to IgE-mediated anaphylaxis and are treated identically with epinephrine. The distinction matters for diagnosis and prevention, not for acute management.
Anaphylaxis vs anaphylactoid vs severe allergic reaction
| Feature | IgE-mediated anaphylaxis | Anaphylactoid reaction | Severe local/systemic allergic reaction (non-anaphylaxis) |
|---|---|---|---|
| Mechanism | IgE cross-linking → mast cell degranulation | Direct mast cell degranulation (no IgE) | IgE-mediated; localized or systemic without hemodynamic compromise |
| Prior sensitization required? | Yes — cannot occur on first exposure | No — can occur on first exposure | Yes for IgE-mediated forms |
| Common triggers | Penicillin, foods, venom, latex | IV contrast, aspirin/NSAIDs, opioids, vancomycin | Contact dermatitis, mild food reaction, urticaria without systemic involvement |
| Hemodynamic compromise? | Yes — defining feature of anaphylaxis | Yes — identical severity | No — distinguishes this category |
| Tryptase level | Elevated (mast cell activation marker) | May be normal or mildly elevated | Normal |
| Treatment | Epinephrine IM — first-line | Epinephrine IM — first-line (identical) | Antihistamines ± corticosteroids; epinephrine not indicated unless systemic signs develop |
| NCLEX point | Requires prior sensitization — always | "First exposure" reactions to contrast dye: anaphylactoid, not anaphylaxis | Urticaria + itching alone ≠ anaphylaxis; epinephrine not yet required |
NCLEX tip 2: The NCLEX will test whether you can distinguish a severe allergic reaction (hives, itching — treat with diphenhydramine) from anaphylaxis (cardiovascular compromise + multi-system involvement — treat with epinephrine). The key differentiator is hemodynamic compromise or airway involvement.
Clinical presentation and assessment
Anaphylaxis involves at least two body systems simultaneously — that multi-system pattern is what distinguishes it from a localized allergic reaction.
Cutaneous (80–90% of cases):
- Urticaria (hives), angioedema (especially periorbital and lip), flushing, pruritus
- Skin findings are absent in up to 20% of cases — absence does NOT rule out anaphylaxis
Respiratory (50–60% of cases):
- Bronchospasm → wheezing, chest tightness, decreased peak flow
- Upper airway: stridor, hoarseness, dysphonia — indicate laryngeal edema
- Respiratory failure is the primary cause of anaphylactic death in food-triggered reactions
Cardiovascular (30–35% of cases):
- Hypotension: systolic BP drop ≥30 mmHg from baseline, or absolute SBP <90 mmHg
- Tachycardia (may be bradycardic in rare cases — Bezold-Jarisch reflex)
- Cardiovascular collapse is the primary cause of anaphylactic death in medication/venom-triggered reactions
Gastrointestinal (25–30% of cases):
- Nausea, vomiting, crampy abdominal pain, diarrhea
- GI symptoms without cutaneous or cardiovascular involvement rarely represent anaphylaxis
Neurological:
- Anxiety, sense of impending doom (a classic presenting complaint — take it seriously)
- Altered mental status, syncope from cerebral hypoperfusion
- Perioral tingling or metallic taste
Diagnostic criteria (World Allergy Organization): Anaphylaxis is likely when any one of the following is met:
- Acute onset of skin/mucosal symptoms PLUS respiratory compromise or cardiovascular compromise
- Two or more of the following after exposure to a likely allergen: skin/mucosal involvement, respiratory compromise, cardiovascular compromise, persistent GI symptoms
- Hypotension after exposure to a known allergen for that patient
NCLEX tip 3: A nursing student’s NCLEX scenario will often present the “sense of impending doom” as the patient’s first complaint before overt hemodynamic changes — this is an early warning sign that mandates immediate assessment and preparation of epinephrine.
Nursing assessment: head-to-toe priorities
A rapid, systematic assessment is essential — anaphylaxis can deteriorate within seconds. Incorporate this into the head-to-toe assessment framework but compress it for the emergency context.
Airway (immediate):
- Listen for stridor — the hallmark of upper airway obstruction from laryngeal edema
- Assess voice quality: hoarseness or “hot potato” voice indicates supraglottic edema
- Prepare for emergent intubation; early intubation is safer than delayed intubation after airway swells further
Breathing:
- Auscultate for wheezing (lower airways) vs stridor (upper airway) — treatment differs
- Assess oxygen saturation — target SpO2 ≥94%
- Respiratory rate and work of breathing (nasal flaring, accessory muscle use, tripod positioning)
Circulation:
- BP, HR, capillary refill, skin color and temperature (distributive shock → warm extremities early, then cold late)
- IV access: two large-bore peripheral IVs; anticipate need for IV fluid resuscitation
Disability/neurological:
- Level of consciousness, orientation
- Anxiety, agitation, sense of impending doom
Exposure/environment:
- Identify and remove the trigger if still present (remove stinger by scraping, stop IV infusion of suspected drug)
- Ask: “Did you eat anything new? Were you stung? Did you receive a new medication?” Timing of exposure helps confirm diagnosis
NCLEX tip 4: The priority assessment action before epinephrine administration is airway assessment. If the airway is compromised, epinephrine is still first-line — but the nurse must simultaneously call for intubation equipment and anesthesia/emergency team.
Treatment sequence with nursing rationale
| Step | Intervention | Dose/detail | Nursing rationale |
|---|---|---|---|
| 1 | Remove trigger, call for help | Stop offending drug infusion; scrape bee stinger; activate emergency response | Ongoing antigen exposure perpetuates degranulation; early team activation shortens time to advanced airway if needed |
| 2 | Epinephrine IM — anterolateral thigh | Adult: 0.3 mg (1:1,000 concentration); pediatric: 0.01 mg/kg (max 0.5 mg); repeat every 5–15 min PRN | Alpha-1 effect reverses vasodilation; beta-1 increases HR and cardiac output; beta-2 causes bronchodilation; IM thigh achieves peak serum level faster than deltoid IM |
| 3 | Position patient | Supine + legs elevated (shock); 30–45° upright if respiratory distress; left lateral if pregnant | Trendelenburg/legs-elevated increases venous return and preload; upright reduces diaphragm compression in severe bronchospasm; left lateral shifts gravid uterus off IVC |
| 4 | High-flow oxygen | 15 L/min via non-rebreather mask; titrate SpO2 to ≥94% | Counteracts hypoxia from bronchospasm and ventilation-perfusion mismatch; supports myocardial oxygen delivery during shock state |
| 5 | IV access + fluid resuscitation | Two large-bore IVs; isotonic saline 1–2 L bolus rapidly; reassess frequently | Up to 35% of circulating volume can shift extravascularly; rapid fluid replacement supports preload and cardiac output. Mechanism mirrors septic shock — distributive etiology |
| 6 | Diphenhydramine (H1 blocker) | 25–50 mg IV/IM; also consider famotidine (H2 blocker) 20 mg IV | Reduces urticaria and pruritus; does NOT reverse bronchospasm or hypotension; H2 blockers block cardiac H2 receptors and further reduce cutaneous vasodilation — adjunct only |
| 7 | Systemic corticosteroids | Methylprednisolone 125 mg IV or hydrocortisone 200 mg IV; or dexamethasone 8–10 mg IV | Reduce late-phase mediator synthesis and blunt biphasic reaction; onset 4–6 hours — no acute hemodynamic effect; do not delay epinephrine waiting for steroid to take effect |
| 8 | Inhaled beta-agonist (bronchospasm) | Albuterol nebulized PRN if bronchospasm persists despite epinephrine | Targets lower airway smooth muscle directly; second-line to epinephrine; does NOT address upper airway edema or cardiovascular collapse |
| 9 | Vasopressors (refractory hypotension) | Norepinephrine 0.1–0.5 mcg/kg/min IV; dopamine or vasopressin as alternatives | For anaphylaxis refractory to multiple doses of epinephrine; consider glucagon 1–2 mg IV if patient on beta-blockers (beta-blockers blunt epinephrine response). See vasopressor drug classes. |
| 10 | Observation period | Minimum 4 hours after symptom resolution; 8–24 hours if severe or biphasic history | Mandatory to detect biphasic reaction; discharging after symptoms resolve without observation period is a clinical and medicolegal error |
NCLEX tip 5: The NCLEX will test sequence. The correct order is: (1) epinephrine, (2) positioning, (3) oxygen, (4) IV access. Antihistamines and corticosteroids appear later in the sequence because they do not address the immediate life threats.
NCLEX tip 6: A patient on beta-blockers may not respond to standard epinephrine dosing. Glucagon is the rescue agent because it activates adenylyl cyclase independently of beta-adrenergic receptors, increasing cAMP and triggering positive inotropic and chronotropic effects.
Epinephrine administration routes
| Route | Concentration | Dose (adult) | When appropriate | NCLEX point |
|---|---|---|---|---|
| IM — anterolateral thigh | 1:1,000 (1 mg/mL) | 0.3–0.5 mg | First-line for ALL anaphylaxis — fastest peak serum level via thigh vs deltoid | Anterolateral thigh is the mandated injection site — vastus lateralis muscle absorbs rapidly due to high muscle mass and vascularity |
| IM — deltoid | 1:1,000 (1 mg/mL) | 0.3–0.5 mg | Acceptable if thigh not accessible; slower peak than thigh | Thigh is preferred — deltoid has lower muscle mass and slower absorption kinetics in emergencies |
| IV push (bolus) | 1:10,000 (0.1 mg/mL) | 0.1–0.2 mg (slow push) | Cardiac arrest or refractory anaphylaxis failing multiple IM doses only | IV bolus epinephrine at standard 0.3 mg IM dose causes severe hypertension, tachyarrhythmia, and myocardial ischemia — the diluted concentration is NOT optional |
| IV infusion (drip) | Variable — typically 1 mg in 250 mL NS | 1–10 mcg/min, titrated | Refractory anaphylaxis requiring sustained vasopressor support | Continuous monitoring mandatory; titrate to MAP ≥65 mmHg |
| Auto-injector (EpiPen) | 1:1,000 (1 mg/mL) | Adult: 0.3 mg; Jr (≤30 kg): 0.15 mg | Community/pre-hospital setting — self-administration by patient or caregiver | Inject into outer thigh, hold firmly for 10 seconds; can inject through clothing; discard used device; send patient to ED — auto-injector dose may not be sufficient for severe reactions |
| Subcutaneous (SC) | 1:1,000 (1 mg/mL) | 0.3 mg | Historical — no longer recommended for anaphylaxis | SC absorption is slower and less reliable than IM in shock states due to vasoconstriction; IM is superior — do not use SC route for anaphylaxis |
NCLEX tip 7: The 1:1,000 vs 1:10,000 concentration distinction is a high-yield NCLEX drug calculation trap. 1:1,000 = 1 mg/mL (used for IM). 1:10,000 = 0.1 mg/mL (used for IV cardiac arrest). Giving 1:1,000 IV will cause hypertensive crisis and potential cardiac arrest.
Biphasic anaphylaxis
Biphasic anaphylaxis is the recurrence of anaphylactic symptoms — without re-exposure to the trigger — after apparent complete resolution. It occurs in 4–23% of anaphylaxis cases, most commonly 4–12 hours after the initial reaction (range: 1–72 hours). The second phase can be more severe than the initial reaction.
Risk factors for biphasic reaction:
- Delayed epinephrine administration (>30 minutes after symptom onset)
- Large antigen dose
- Severe initial reaction requiring multiple epinephrine doses
- Absence of corticosteroids during initial management
- History of prior biphasic reactions
Observation period guidelines:
- Minimum 4 hours after symptom resolution for mild-to-moderate reactions
- 8–24 hours for severe reactions, those requiring multiple epinephrine doses, or patients with prior biphasic episodes
- No validated tool exists to predict who will have a biphasic reaction — observation is mandatory, not risk-stratified
NCLEX tip 8: If an anaphylaxis NCLEX scenario asks “the patient’s symptoms have resolved after epinephrine — what is the appropriate next action?” — the answer is NOT discharge. It is observation for a minimum of 4 hours and patient education about biphasic reactions.
Discharge education (after observation):
- Prescribe and teach EpiPen use before discharge (demonstrate, have patient return-demonstrate)
- Medic Alert bracelet — especially for unknown triggers or severe reactions
- Allergy consultation for trigger identification and desensitization counseling
- Strict trigger avoidance instructions
- Antihistamines for mild breakthrough symptoms — epinephrine for any systemic symptoms
- Written anaphylaxis action plan
Airway management
Laryngeal edema is the most time-critical aspect of anaphylaxis management. The window between early edema (hoarseness, stridor) and complete airway obstruction can be extremely narrow — sometimes under 10 minutes.
Airway assessment sequence:
- Voice quality — any change from baseline (hoarseness, muffled, high-pitched) = act immediately
- Stridor — high-pitched inspiratory noise indicates partial upper airway obstruction; is a true emergency
- Drooling or inability to swallow secretions — late sign of severe supraglottic edema
- SpO2 — may remain normal until obstruction is near-complete; do not rely on pulse oximetry alone
Airway interventions:
- Early: high-flow O2, epinephrine (may partially reverse edema)
- Intermediate: bag-valve-mask ventilation if spontaneous breathing insufficient
- Definitive: endotracheal intubation — should be performed early before edema makes laryngoscopy impossible
- Rescue: cricothyrotomy (surgical airway) if intubation fails due to complete laryngeal edema
NCLEX tip 9: The NCLEX will test priority-setting when both respiratory and cardiovascular compromise are present. The answer follows the ABC framework — airway takes priority. However, in anaphylaxis, epinephrine addresses both simultaneously (bronchodilation + vasopressor), which is why it is always the first drug intervention.
Patients with known anaphylaxis history who work in high-risk environments (healthcare workers with latex allergy, food industry workers with severe food allergy) require specific environmental controls. Review emergency nursing assessment frameworks for systematic approaches to multi-system emergencies.
Special populations
Pregnant patients:
- Position in left lateral decubitus — reduces aortocaval compression from the gravid uterus
- Epinephrine is NOT contraindicated in pregnancy — the risk of untreated anaphylaxis to mother and fetus far exceeds any theoretical fetal risk
- Fetal heart rate monitoring after stabilization
- Obstetrics team involvement for any anaphylaxis event in pregnancy
Pediatric patients:
- Epinephrine dose: 0.01 mg/kg IM (max 0.5 mg) — EpiPen Jr (0.15 mg) for weight <30 kg
- Food allergy is the most common pediatric trigger (peanut, tree nut, milk, egg)
- Children may not articulate symptoms — observe for unusual behaviors (rubbing throat, sudden refusal of food, excessive crying)
Elderly patients:
- Cardiovascular disease increases risk of epinephrine-induced arrhythmia — give epinephrine anyway; withholding it is more dangerous
- Medications: beta-blockers blunt epinephrine response (give glucagon); ACE inhibitors increase angioedema risk
- Baseline hypotension may mask early hemodynamic compromise
Patients on beta-blockers:
- Epinephrine still first-line — titrate doses
- Glucagon 1–2 mg IV over 5 minutes followed by infusion 5–15 mcg/min is the specific adjunct for beta-blocker–blunted anaphylaxis
- May also require atropine for epinephrine-refractory bradycardia
Drug classifications: adjunct medications
Understanding the pharmacological role of each agent prevents medication errors and helps with drug classification NCLEX questions.
H1-receptor antagonists (antihistamines):
- Diphenhydramine 25–50 mg IV/IM — blocks histamine at H1 receptors; reduces urticaria and pruritus
- Cetirizine 10 mg PO — second-generation option with less sedation
- Critical limitation: onset 15–30 minutes; does NOT reverse bronchospasm, hypotension, or laryngeal edema — cannot substitute for epinephrine
H2-receptor antagonists:
- Ranitidine (now withdrawn — replaced by famotidine) or famotidine 20 mg IV
- Blocks H2 receptors in cardiac and vascular tissue; reduces vasodilation and histamine-mediated tachycardia
- Evidence base weaker than H1 blockers; used as adjunct in severe or refractory urticaria/angioedema
Corticosteroids:
- Methylprednisolone (Solu-Medrol) 1–2 mg/kg IV (typical adult dose 125 mg) — inhibits arachidonic acid pathway, reduces late-phase mediator production
- Hydrocortisone 200 mg IV — also used
- Dexamethasone 8–10 mg IV — longer-acting alternative with less mineralocorticoid effect
- Onset: 4–6 hours — no acute benefit; primary role is reducing biphasic reaction risk and prolonged inflammation
Beta-2 agonists:
- Albuterol (salbutamol) nebulized — bronchodilation via beta-2 receptor stimulation in lower airways
- Adjunct for persistent lower airway bronchospasm after epinephrine; does not treat upper airway edema or distributive shock
Vasopressors (refractory cases):
- Norepinephrine: alpha-1 dominant vasopressor; first-line for distributive shock refractory to epinephrine
- Vasopressin: V1 receptor vasopressor; useful adjunct when catecholamine-refractory hypotension develops
- See septic shock nursing for vasopressor titration frameworks — the hemodynamic management parallels distributive shock
NCLEX tip 10: Ranitidine is no longer FDA-approved (withdrawn in 2020 due to NDMA contamination). Current NCLEX items and clinical practice use famotidine as the H2 blocker. If a question lists ranitidine as an option, it remains pharmacologically correct for anaphylaxis adjunct therapy in historical context, but famotidine is the preferred current choice.
NCLEX scenarios and common traps
NCLEX tip 11: A patient develops urticaria, throat tightening, and audible wheezing 10 minutes after receiving IV ampicillin. BP 84/52. HR 124. What is the priority nursing action?
The correct answer is to administer epinephrine IM 0.3 mg into the anterolateral thigh — not to call the physician first, not to administer diphenhydramine, not to stop the infusion and reassess. Stopping the infusion is also correct and should occur simultaneously, but it is not the priority action over epinephrine.
NCLEX tip 12: A patient who received epinephrine 30 minutes ago for anaphylaxis is now symptom-free. The family asks when they can go home. The correct response is that the patient requires a minimum 4-hour observation period because of the risk of biphasic anaphylaxis — a second reaction that can occur without re-exposure.
Common NCLEX trap — antihistamines as primary treatment: NCLEX scenarios frequently offer diphenhydramine as a plausible first-line intervention. This is always wrong in confirmed or suspected anaphylaxis. Antihistamines treat symptoms of mild allergic reaction. They do not prevent death from anaphylaxis. Epinephrine always precedes antihistamines.
Common NCLEX trap — epinephrine contraindicated in cardiac patients: There is no absolute contraindication to epinephrine in anaphylaxis. The risk-benefit calculation always favors epinephrine in true anaphylaxis, including in patients with coronary artery disease or arrhythmia history.
Common NCLEX trap — deltoid injection site: Epinephrine in anaphylaxis is administered to the anterolateral thigh (vastus lateralis), not the deltoid. The thigh achieves higher peak plasma concentrations faster. This detail appears consistently on NCLEX.
Common NCLEX trap — SC route: Subcutaneous epinephrine is not recommended for anaphylaxis. In a shocked patient, peripheral vasoconstriction makes SC absorption unreliable. IM is required.
NCLEX tip 13: If a scenario involves anaphylaxis occurring during a blood transfusion, the correct sequence is: (1) stop the transfusion immediately, (2) maintain IV access with normal saline, (3) notify the provider, (4) administer epinephrine per protocol. Stopping the transfusion is the first action before epinephrine because the antigen must be removed — but this should happen simultaneously with preparing epinephrine, not as a substitute for it.
Patient and family education
Discharge education after anaphylaxis is a NCLEX priority topic and a clinical responsibility. Patients with anaphylaxis are at lifelong risk of recurrence and require a comprehensive education plan.
EpiPen training:
- Remove blue safety cap
- Hold orange tip pointing down
- Swing and firmly push orange tip into outer thigh (through clothing if necessary)
- Hold in place for 10 seconds, then remove
- Massage the area for 10 seconds
- Call 911 — the auto-injector is a bridge to emergency care, not definitive treatment
- Lie down with legs elevated after injection if possible
Trigger avoidance:
- Read ingredient labels meticulously (food-triggered allergy)
- Inform all healthcare providers of allergy — document in all medical records
- Carry two EpiPens at all times (dose may need repeating before EMS arrives)
- Avoid ACE inhibitors if angioedema risk is elevated (increased risk with ACE inhibitor use)
Medical alert:
- Medic Alert bracelet/ID is strongly recommended for all patients with known anaphylaxis triggers — communicates allergy to EMS if patient is unconscious
When to use the EpiPen:
- Any systemic symptoms after exposure to known trigger: throat tightening, voice change, difficulty breathing, dizziness, loss of consciousness
- Uncertainty: if in doubt, use it — epinephrine harms far less than anaphylaxis untreated
Follow-up care:
- Allergy/immunology consultation for trigger identification
- Skin prick testing and specific IgE testing to confirm allergens
- Venom immunotherapy for insect venom allergy (85–95% protective for future stings)
Summary: the anaphylaxis NCLEX framework
Anaphylaxis NCLEX questions test four competencies: (1) recognizing anaphylaxis vs a severe allergic reaction, (2) knowing epinephrine is first-line and the correct dose/site, (3) understanding biphasic reactions and mandatory observation, and (4) identifying what antihistamines and corticosteroids cannot do. If a scenario presents a patient with multi-system involvement after an allergen exposure, the answer sequence is: epinephrine IM thigh → position → oxygen → IV access → antihistamines → corticosteroids → observation.
The asthma nursing reference covers bronchospasm management in more depth for the respiratory component. For a systematic approach to the emergency nursing assessment underlying all of these priorities, the head-to-toe assessment reference provides the structural framework.